Cargando…
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
Cannabidiol (CBD) is a major Cannabis sativa constituent, which does not cause the typical marijuana psychoactivity. However, it has been shown to be active in a numerous pharmacological assays, including mice tests for anxiety, obsessive-compulsive disorder, depression and schizophrenia. In human t...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945002/ https://www.ncbi.nlm.nih.gov/pubmed/27416026 http://dx.doi.org/10.1371/journal.pone.0158779 |
_version_ | 1782442850248556544 |
---|---|
author | Breuer, Aviva Haj, Christeene G. Fogaça, Manoela V. Gomes, Felipe V. Silva, Nicole Rodrigues Pedrazzi, João Francisco Del Bel, Elaine A. Hallak, Jaime C. Crippa, José A. Zuardi, Antonio W. Mechoulam, Raphael Guimarães, Francisco S. |
author_facet | Breuer, Aviva Haj, Christeene G. Fogaça, Manoela V. Gomes, Felipe V. Silva, Nicole Rodrigues Pedrazzi, João Francisco Del Bel, Elaine A. Hallak, Jaime C. Crippa, José A. Zuardi, Antonio W. Mechoulam, Raphael Guimarães, Francisco S. |
author_sort | Breuer, Aviva |
collection | PubMed |
description | Cannabidiol (CBD) is a major Cannabis sativa constituent, which does not cause the typical marijuana psychoactivity. However, it has been shown to be active in a numerous pharmacological assays, including mice tests for anxiety, obsessive-compulsive disorder, depression and schizophrenia. In human trials the doses of CBD needed to achieve effects in anxiety and schizophrenia are high. We report now the synthesis of 3 fluorinated CBD derivatives, one of which, 4'-F-CBD (HUF-101) (1), is considerably more potent than CBD in behavioral assays in mice predictive of anxiolytic, antidepressant, antipsychotic and anti-compulsive activity. Similar to CBD, the anti-compulsive effects of HUF-101 depend on cannabinoid receptors. |
format | Online Article Text |
id | pubmed-4945002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-49450022016-08-08 Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects Breuer, Aviva Haj, Christeene G. Fogaça, Manoela V. Gomes, Felipe V. Silva, Nicole Rodrigues Pedrazzi, João Francisco Del Bel, Elaine A. Hallak, Jaime C. Crippa, José A. Zuardi, Antonio W. Mechoulam, Raphael Guimarães, Francisco S. PLoS One Research Article Cannabidiol (CBD) is a major Cannabis sativa constituent, which does not cause the typical marijuana psychoactivity. However, it has been shown to be active in a numerous pharmacological assays, including mice tests for anxiety, obsessive-compulsive disorder, depression and schizophrenia. In human trials the doses of CBD needed to achieve effects in anxiety and schizophrenia are high. We report now the synthesis of 3 fluorinated CBD derivatives, one of which, 4'-F-CBD (HUF-101) (1), is considerably more potent than CBD in behavioral assays in mice predictive of anxiolytic, antidepressant, antipsychotic and anti-compulsive activity. Similar to CBD, the anti-compulsive effects of HUF-101 depend on cannabinoid receptors. Public Library of Science 2016-07-14 /pmc/articles/PMC4945002/ /pubmed/27416026 http://dx.doi.org/10.1371/journal.pone.0158779 Text en © 2016 Breuer et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Breuer, Aviva Haj, Christeene G. Fogaça, Manoela V. Gomes, Felipe V. Silva, Nicole Rodrigues Pedrazzi, João Francisco Del Bel, Elaine A. Hallak, Jaime C. Crippa, José A. Zuardi, Antonio W. Mechoulam, Raphael Guimarães, Francisco S. Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects |
title | Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects |
title_full | Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects |
title_fullStr | Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects |
title_full_unstemmed | Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects |
title_short | Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects |
title_sort | fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945002/ https://www.ncbi.nlm.nih.gov/pubmed/27416026 http://dx.doi.org/10.1371/journal.pone.0158779 |
work_keys_str_mv | AT breueraviva fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT hajchristeeneg fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT fogacamanoelav fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT gomesfelipev fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT silvanicolerodrigues fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT pedrazzijoaofrancisco fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT delbelelainea fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT hallakjaimec fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT crippajosea fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT zuardiantoniow fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT mechoulamraphael fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects AT guimaraesfranciscos fluorinatedcannabidiolderivativesenhancementofactivityinmicemodelspredictiveofanxiolyticantidepressantandantipsychoticeffects |